Search

Commercial infrared (IR) nonlinear optical (NLO) materials are mainly from chalcopyrite‐type AMQ2 (A = Ag, Zn, M = Ga, Ge, Q = S, Se, P) crystals such as AgGaS2 (AGS), AgGaSe2 (AGSe), and ZnGeP2 (ZGP), in which the basic NLO‐active groups are MQ4 tetrahedral units. However, the small anisotropic character of them critical for small birefringence hinders the practical applications in the available IR wavelength range. In this study, a novel strategy for modulating birefringence is proposed using a cation regulation‐driven compressed hypertetrahedral layer approach and a family of AAg2MS4 (A = Na, K, Rb; M = P, As) IR NLO crystals are successfully obtained. Remarkably, the title compounds increase the birefringence to 0.12–0.15, about three times larger than that of AGS (0.04), while they can maintain large bandgaps and strong NLO effects. In addition, they exhibit congruent‐melting properties, beneficial for bulk single crystal growth. The work offers a firsthand access for designing and fabricating high‐performance IR NLO materials. [ABSTRACT FROM AUTHOR]

Comprehensive thermodynamic calculations and high‐temperature experiments are performed to systematically evaluate the effect of calcium and magnesium additions on the modification and control of inclusions in AH36 ship plate steel. The results show that Al2O3 or MgAl2O4 inclusions are formed under the casting temperature conditions. Calcium treatment modifies the inclusions into calcium aluminate, of which components partially fall into the liquidus region, and the aspect ratio and number density of inclusions became smaller, avoiding nozzle clogging, but the inclusions are easy to gather and grow up, which would affect the steel properties. Magnesium treatment modifies the inclusions into dispersed magnesium‐aluminum spinel with small size. However, the number density and aspect ratio of inclusions increase, as well as the melting points of inclusions are high, which would easily cause nozzle clogging. When calcium–magnesium synergistic treatment, with the increase of magnesium proportion, the inclusions types increased, and the liquidus area of inclusions became narrower until it disappeared. Synergistic treatment with more calcium and less magnesium (Ca2Mg1) is optimal since the inclusions were fine and diffuse, and the corresponding liquidus area of inclusions is wider than the calcium treatment. [ABSTRACT FROM AUTHOR]

The highly strained, phenylene‐derived organic cages are typically regarded as very rigid entities, yet their deformation potential and supramolecular properties remain underexplored. Herein, we report a pliable conjugated phenylene nanocage by synergistically merging rigid and flexible building blocks. The anisotropic cage molecule contains branched phenylene chains capped by a calix[6]arene moiety, the delicate conformational changes of which endow the cage with a remarkably deformable cavity. When complexing with fullerene guests, the cage showcases excellent guest‐adaptivity, with its cavity volume capable of swelling by as much as 85 %. [ABSTRACT FROM AUTHOR]

The highly strained, phenylene‐derived organic cages are typically regarded as very rigid entities, yet their deformation potential and supramolecular properties remain underexplored. Herein, we report a pliable conjugated phenylene nanocage by synergistically merging rigid and flexible building blocks. The anisotropic cage molecule contains branched phenylene chains capped by a calix[6]arene moiety, the delicate conformational changes of which endow the cage with a remarkably deformable cavity. When complexing with fullerene guests, the cage showcases excellent guest‐adaptivity, with its cavity volume capable of swelling by as much as 85 %. [ABSTRACT FROM AUTHOR]

Cristobalite‐type boron phosphate BPO4, an important nonlinear‐optical (NLO) crystal, exhibits nearly the largest bandgap (Eg ≈ 9.3 eV) and a significant second‐harmonic‐generation (SHG) effect (d36 ≈ 0.7 pm V−1) in the deep‐ultraviolet (DUV, < 200 nm) spectral region. However, its conventional tetrahedral framework structure tends to have low structural anisotropy, resulting in a severe deficiency of birefringence (Δn < 0.01), which fails to achieve DUV birefringent phase matching. In this work, the local anisotropy of tetrahedral structures are proposed to enlarge by constructing van der Waals (vdW) anisotropic motifs under synthetic chemical conditions, which can effectively convert unattainable extreme external forces into internal stresses in chemical bond structures. Depending on unique hierarchical vdW assemblies, enormous tetrahedral distortions can be achieved by stable in‐plane or in‐line bond matching between rigid tetrahedral primitives. First‐principles calculations demonstrate that the birefringence of 2D layered and 1D chained BPO4 achieved by vdW engineering are scaled from Δn < 0.01 to 0.07–0.13, with the shortest birefringent phase‐matched wavelengths down to DUV 189–154 nm. The finding is of seminal importance for the design of vdW NLO crystals in structural chemistry and would provide opportunities to explore unique vdW DUV NLO materials under extreme synthetic conditions. [ABSTRACT FROM AUTHOR]

Aim: To evaluate the effect of age and disease duration on the efficacy and safety of iGlarLixi versus insulin glargine 100 units/ml (iGlar) or lixisenatide (Lixi) alone in Asian people with type 2 diabetes (T2D) uncontrolled on oral antidiabetic drugs (LixiLan‐O‐AP) or basal insulin ± oral antidiabetic drugs (LixiLan‐L‐CN). Materials and Methods: In this post hoc analysis, the glycated haemoglobin (HbA1c) changes were assessed from baseline to week 24 (LixiLan‐O‐AP) or 30 (LixiLan‐L‐CN) in subgroups defined by baseline age (<65, ≥65 years) and duration of T2D. The proportion who achieved the composite of HbA1c <7% (<53.0 mmol/mol) without weight gain and without symptomatic hypoglycaemia (plasma glucose ≤3.9 mmol/L) and the incidences of hypoglycaemia and gastrointestinal disorders were also analysed. Results: HbA1c reductions were consistently greater with iGlarLixi versus iGlar or Lixi across all subgroups, including participants aged ≥65 years and those with T2D for ≥15 or ≥20 years. Greater proportions of participants achieved HbA1c <7% (<53.0 mmol/mol) without weight gain or hypoglycaemia with iGlarLixi versus iGlar or Lixi, regardless of age or T2D duration. Hypoglycaemia incidence was similar with iGlarLixi versus iGlar across most subgroups; the incidence of gastrointestinal disorders was lower with iGlarLixi versus Lixi in all subgroups. Conclusions: iGlarLixi showed consistent efficacy and safety across all age and disease duration subgroups in Asian people with uncontrolled T2D, including older individuals and those with longstanding disease. [ABSTRACT FROM AUTHOR]